| Literature DB >> 30283795 |
Ning Duan1, Yang-Heng Zhang2, Wen-Mei Wang1, Xiang Wang3.
Abstract
Labial and oral melanotic macules are commonly encountered in a broad range of conditions ranging from physiologic pigmentation to a sign of an underlying life-threatening disease. Although Laugier-Hunziker syndrome (LHS) shares some features of labial and oral pigmentation with a variety of conditions, it is a benign and acquired condition, frequently associated with longitudinal melanonychia. Herein, the demographic, clinical, dermoscopic, and pathological aspects of LHS were reviewed comprehensively. The important differential diagnoses of mucocutaneous and nail pigmentation are provided. An accurate diagnosis is crucial to design a reasonable medical strategy, including management options, malignant transformation surveillance, and psychological support. It is important that clinicians conduct long-term follow-up and surveillance due to the potential risks of malignant transformation and local severe complications in some conditions.Entities:
Keywords: Carney complex; Dermoscopy; Differential diagnosis; Laugier-Hunziker syndrome; Melanonychia; Neurofibromatosis type 1; Pathology; Peutz-Jeghers syndrome; Pigmentation
Year: 2018 PMID: 30283795 PMCID: PMC6163135 DOI: 10.12998/wjcc.v6.i10.322
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.337
Geographical distribution of published cases affected with Laugier-Hunziker syndrome
| 1 | France | 59 | 29 | [1,14,20-22,24,26,27,30,31] |
| 2 | Italy | 33 | 16 | [11,12,18,25,28,29,33,34-37,40,63] |
| 3 | China | 30 | 14.5 | [5,9,10,19,23,58,72] |
| 4 | United States | 14 | 7 | [13,16,32,42,46,51,60,67-69,73,77,85,88] |
| 5 | United Kingdom | 13 | 6 | [3,39,45,49,52,54,76] |
| 6 | Germany | 12 | 6 | [40,61] |
| 7 | India | 8 | 4 | [47,56,57,70,71,81,86] |
| 8 | Turkey | 6 | 3 | [7,50,53,62,75,83] |
| 9 | Greece | 5 | 2 | [6,40,48] |
| 10 | Japan | 5 | 2 | [8,44,55,59] |
| 11 | Lebanon | 3 | 1.5 | [17] |
| 12 | Portugal | 2 | 1 | [23,43] |
| 13 | Brazil | 2 | 1 | [65,78] |
| 14 | Spain | 2 | 1 | [66] |
| 15 | Australia | 2 | 1 | [87] |
| 16 | Finland | 1 | 0.5 | [4] |
| 17 | Ireland | 1 | 0.5 | [15] |
| 18 | Russia | 1 | 0.5 | [38] |
| 19 | Switzerland | 1 | 0.5 | [41] |
| 20 | South Korea | 1 | 0.5 | [64] |
| 21 | Austria | 1 | 0.5 | [74] |
| 22 | Serbia | 1 | 0.5 | [79] |
| 23 | Chile | 1 | 0.5 | [80] |
| 24 | Romania | 1 | 0.5 | [82] |
| 25 | Singapore | 1 | 0.5 | [84] |
Distribution of involved locations of pigmentary lesions in Laugier-Hunziker syndrome
| Lip | 75% (154/206) | [1,3-16,18,19,21-25,27-29,31-38,40,41,43-52,54-68,70-73,75-78,80,83,85-88] | |
| Oral cavity | 68% (140/206) | [1,3-9,11-19,21-24,26,27,29,31-33,35-44,46,47,50-60,62-76,78,79,81,82,84-88] | |
| Acral area | Nail | 47% (96/206) | [1,3-10,12,14-17,19,22,23,25-27,31,32,34,39-41,43,44,47,49,50,52-54,56-59,61,63-66,68-72,77-84,86] |
| Periungual area | 8% (17/206) | [8,14,16,25,31,34,43,47,50,54,64,65,71,73,77,79,81] | |
| Finger | 13% (26/206) | [5,8,9,11,14,19,21,41,43,49,55-57,59,60,66,70-72,74,76,84-86,88] | |
| Palm | 4% (8/206) | [7,43,44,46,59,60,62,81] | |
| Toes | 3% (6/206) | [19,56,59,70,84,86] | |
| Sole | 3% (6/206) | [7,21,46,59,62] | |
| Genitalia | Penis | 24% (17/70) | [20-23,46] |
| Vulva or labia majora | 10% (13/127) | [7,12,15,17,21,30,58,74] | |
| Anal mucosa and perianal area | 1.5% (3/206) | [21,41] | |
| Conjunctiva and sclera | 4% (9/206) | [6,7,17,19,23,46,60,83] | |
| Eyebrow and periorbital area | 1.5% (3/206) | [41,53,71] | |
| Pharynx | 0.5% (1/206) | [4] | |
| Esophagus | 0.5% (1/206) | [44] | |
| Neck, thorax, and abdomen | 1% (2/206) | [25,81] | |
| Back | 0.5% (1/206) | [50] | |
| Elbow | 1% (2/206) | [43,76] | |
| Pretibial area | 0.5% (1/206) | [62] | |
Frequency of genitalia involvement of pigmentation was assessed according to the known sum of male or female cases.
Figure 1Lenticular melanotic macule on the lower lip of a Laugier-Hunziker syndrome patient.
Figure 2Dermoscopic findings of the Laugier-Hunziker syndrome patient. Granular (closed arrowhead) and linear (open arrowhead) patterns coexist in the labial pigmented lesion.
Figure 3Pathological findings of the Laugier-Hunziker syndrome patient. Accumulated melanin in the basal layer (closed arrowhead) and slightly increased melanophages in the lamina propria (open arrowhead) (HE stain × 200).
Various conditions associated with labial or oral pigmentation
| Exogenous origin | Amalgam tattoo | Tobacco-associated melanin pigmentation |
| (smoker’s melanosis) | ||
| Topical medications | Drugs ( | |
| Graphite tattoo ( | Heavy metals (including bismuth, mercury, silver, lead, gold, arsenic, tin, copper, brass, zinc, cadmium, chrome, and manganese) | |
| Endogenous origin | Melanotic macule | Physiologic (racial) pigmentation |
| Melanocytic nevus | Posttraumatic or postinflammatory pigmentation | |
| Melanoacanthoma | Lichen planus | |
| Melanoma | Discoid lupus erythematosus | |
| Hemangioma | LHS | |
| Lentigo maligna | Peutz-Jeghers syndrome | |
| Kaposi sarcoma | Addison’s disease | |
| McCune-Albright syndrome | ||
| Neurofibromatosis type 1 (von Recklinghausen’s disease) | ||
| Carney complex (NAME/LAMB syndrome) | ||
| LEOPARD syndrome (lentiginosis profusa syndrome) | ||
| Cronkhite-Canada syndrome | ||
| Cushing syndrome | ||
| Incontinentia pigmenti syndrome (Bloch-Sulzberger syndrome) | ||
| Acanthosis nigricans | ||
| Dyschromatosis symmetrica hereditaria | ||
| Tuberous sclerosis | ||
| Xeroderma pigmentosum | ||
| Dyskeratosis congenita | ||
| Hemochromatosis | ||
| Fanconi anemia |
Differential diagnosis between Peutz-Jeghers syndrome and Laugier-Hunziker syndrome
| Inheritance | Autosomal dominant ( | Sporadic and acquired |
| Age of onset | Birth to infancy | Adult onset |
| Shape of mucocutaneous pigmented macules | Freckle-like | Lenticular |
| Labial pigmentation | Very common | Very common |
| Oral pigmentation | Common | Very common |
| Perioral, perirhinal, or periorbital pigmentation | Common | Uncommon |
| Nail pigmentation | Uncommon | Very common |
| Acral skin pigmentation | Common | Common |
| Systemic involvement | Gastrointestinal polyposis | None |
| Risk of malignancy | Colon, gastric, small intestinal, pancreatic, breast, ovarian, thyroid, lung, and Sertoli cell (in men) cancers | None |
PJS: Peutz-Jeghers syndrome; LHS: Laugier-Hunziker syndrome.
Figure 4The differentiation and relationship between several main syndromes or systemic disorders characterized by diffuse mucocutaneous pigmentation. Red circle: Malignancy risk; Green circle: Inheritance tendency.
Differential diagnosis of nail pigmentation
| Causation of nail pigmentation | Condition | |
| Nonmelanocytic origin | Exogenous | Dirt |
| Tobacco | ||
| Tar | ||
| Potassium hypermanganate | ||
| Silver nitrate | ||
| Infectious | Bacterial infection | |
| ( | ||
| Onychomycosis | ||
| (fungal infection) | ||
| Traumatic | Subungual hemorrhage | |
| Subungual hematoma | ||
| Neoplastic | Hemangioma | |
| Melanocytic origin | Physiological | Ethnic (racial) melanonychia |
| Nutritional | Vitamin B12 deficiency | |
| Traumatic | Onychotillomania (nail biting) | |
| Frictional melanonychia | ||
| Iatrogenic | Systemic drug-induced melanonychia | |
| ( | ||
| Radiotherapy-induced melanonychia | ||
| Inflammatory | Lichen planus | |
| Psoriasis | ||
| Endocrinic | Addison’s disease | |
| Pregnancy | ||
| Syndromic | LHS | |
| AIDS | ||
| Activated melanocytic | Benign melanocytic hyperplasia | |
| Lentigo simplex | ||
| Nevus | ||
| Neoplastic | Onychopapilloma | |
| Onychomatricoma | ||
| Bowen’s disease | ||
| Melanoma | ||
LHS: Laugier-Hunziker syndrome; AIDS: Acquired immunodeficiency syndrome.